Introduction
============

*Staphylococcus aureus* is a commensal organism found in the nasopharynx and on the skin of humans and other mammals. It can also cause infections in these hosts and cause a range of diseases from mild skin and soft tissue infections to severe systemic infections. The treatment of *S. aureus* infections is hampered by the development of antimicrobial resistance (AMR) in these isolates, such as the acquisition of the SCC*mec* element, which confers methicillin resistance. These isolates are designated as methicillin resistant *S. aureus* (MRSA) and have become a significant burden for the health care system ([@B30]; [@B7]).

Methicillin resistant *S. aureus* isolates are classified based on epidemiologic characteristics into hospital acquired MRSA (HA-MRSA), community acquired MRSA (CA-MRSA), and livestock associated MRSA (LA-MRSA) ([@B46]). These subsets are defined by the source of the isolate and the isolates within each subset tend to share genotypic and phenotypic characteristics, such as degree of AMR and virulence factors. Specific lineages or sequence types (STs) tend to predominate within each group, although there are regional variations. For example, in the United States, ST5 and ST8 are major HA-MRSA and CA-MRSA clones, respectively ([@B3]).

Livestock associated MRSA became a significant public health concern in 2005, when the first report linked MRSA ST398 to swine production facilities ([@B50]). Further investigations indicated swine may serve as the largest reservoir for MRSA outside of hospital settings and motivated considerable research into the potential health risks associated with LA-MRSA ([@B42]). Subsequent research showed the most prevalent lineage of LA-MRSA varied based on geographic location. In European swine populations, ST398 is the most common lineage ([@B2]), while the ST9 lineage predominates in swine in most Asian countries ([@B51]). In the United States, the swine population was found to harbor more diverse STs with isolates of the ST398, ST9, and ST5 lineages ([@B35]; [@B12]; [@B48]). The presence of MRSA ST5 isolates in United States swine herds raised additional public health concerns because the ST5 lineage, unlike the ST398 and ST9 lineages, is not considered livestock adapted but is a highly successful and globally disseminated MRSA lineage in and out of hospital settings ([@B36]; [@B11]; [@B38]). The widespread success of the ST5 lineage has been attributed to its capacity to acquire mobile genetic elements (MGEs) that harbor virulence factors or AMR genes ([@B36]).

Phylogenetic studies employ whole genome sequencing (WGS) technology and data analysis to better understand the epidemiology, origin, and evolution of bacteria ([@B39]; [@B49]; [@B10]; [@B41]). In the case of LA-MRSA, these techniques have been used to assess the relatedness of isolates from the ST398 lineage. LA-MRSA ST398 isolates clustered separately from human ST398 isolates and are suspected to have evolved from an ancestral methicillin susceptible ST398 clade in humans ([@B39]). Similar investigations into the CC97 lineage indicated that isolates causing clinical disease in humans comprise a sub-clade of the LA-MRSA isolates that may have developed an increased capacity for infecting and causing disease in humans ([@B44]). WGS analysis can be used to assess isolate relatedness or determine genetic characteristics that define subsets of isolates, including information about the MGEs harboring virulence factors or AMR genes. Through single nucleotide polymorphism (SNP) discovery within the core genome, the accuracy and resolution power is available to determine phylogenetic relationships and distinguish isolates within highly homogenous lineages, which provides insight in epidemiological investigations ([@B9], [@B10]; [@B40]; [@B41]).

Although previous reports have examined the genetic diversity and relatedness of MRSA isolates from livestock species and humans within the ST398 and CC97 lineages ([@B39]; [@B44]), to date there are no reports using WGS data to evaluate the genetic diversity of MRSA ST5 isolates obtained from swine and human sources. In this study, we used SNP analysis of the core genome to evaluate the population structure and genetic diversity of LA-MRSA ST5 isolates from a variety of swine associated sources and clinical MRSA ST5 isolates from humans with no swine contact to investigate the potential for LA-MRSA ST5 isolates to act as a source for human infections or as a source for MGEs harboring virulence factors or AMR.

Materials and Methods {#s1}
=====================

Isolate Acquisition
-------------------

Swine associated LA-MRSA ST5 isolates were obtained from samples collected while visiting pork farms in the Midwest United States as part of field case investigations completed by Iowa State University (ISU) ([@B12]). Sources for these isolates were swine nasal swabs (38 isolates), the environment within swine facilities (25 isolates), and humans with short-term contact with swine (9 isolates) ([@B12]). Isolates from healthy practicing swine veterinarians were provided by the University of Minnesota (UMN). The isolates (*n* = 9) were acquired from swine veterinarians who participated in a longitudinal study focusing on *S. aureus*. Veterinarians resided in areas of intensive swine production in the Midwest and Southeast United States and had regular (i.e., greater than twice per week) professional contact with pigs ([@B47]). MRSA ST5 isolates from humans with no swine contact were obtained from medical centers associated with the University of California Irvine (UCI) (*n* = 64) ([@B28]) and the University of California, San Francisco (UCSF) (*n* = 8). Isolates were characterized for MLST and *Spa* typed prior to acquisition (Frana et al., 2013; [@B28]; [@B47]). Specific isolate information can be found in **Supplementary Table [S1](#SM2){ref-type="supplementary-material"}**. All isolates were either obtained from samples collected as part of previous studies and obtained through written consistent ([@B12]; [@B28]; [@B47]) or were obtained from samples submitted as part of field case investigations and did not require Institutional Animal Care and Use Committee (IACUC) approval.

Whole Genome Sequencing
-----------------------

Draft genomes were generated as previously described ([@B18],[@B19],[@B20],[@B21],[@B22],[@B23]). Briefly, total genomic DNA was extracted from isolates grown in Trypticase Soy Broth (BD Biosciences, Sparks, MD, United States) using a High Pure PCR Template Preparation Kit (Roche Applied Science, Indianapolis, IN, United States). The Nextera XT DNA sample preparation and index kit (Illumina, San Diego, CA, United States) was used to generate paired-end DNA libraries with 250-bp read length that were sequenced using the MiSeq v2 500 Cycle reagent kit on the Illumina MiSeq platform (Illumina, San Diego, CA, United States). Sequence reads were assembled with MIRA v. 4.0.2^[1](#fn01){ref-type="fn"}^ and annotated using the NCBI Prokaryotic Genome Annotation Pipeline^[2](#fn02){ref-type="fn"}^. Draft genomes and sequence reads have been submitted to GenBank and the Sequence Read Archive (SRA). Accession numbers are provided in **Supplementary Table [S1](#SM2){ref-type="supplementary-material"}**.

Core Genome SNP Discovery
-------------------------

For reference based SNP discovery we used a custom developed pipeline implemented on Galaxy ([@B15]), that was successfully applied for the high resolution genomic epidemiology profiling of various microbial human pathogens ([@B9], [@B10]; [@B40]). Strategies and phylogenetic principles have been described in detail in [@B40]. The MRSA core genome in this study is defined in the samples as the set of genic and intragenic regions that are present in all genomes, not repeated, and do not contain MGEs (which evolve at different rates and are not indicative of evolutionary relationships), such as phages, IS elements, genomic islands or plasmids. These excluded regions were determined for the reference genome Mu50 as follows: NUCmer was used to detect repeat regions by running the reference against itself ([@B6]), integrated bacteriophages were identified using PHAST ([@B54]), ISFinder was used for detection of insertion sequences ([@B43]), and antibiotic resistance cassettes were detected with ResFinder ([@B53]). The SNP discovery and verification pipelines are implemented on Galaxy, and contain the following modules: (i) SNP discovery and typing, (ii) SNP curation, (iii) SNP annotation, (iv) SNP distribution, and (v) SNP phylogeny.

### SNP Discovery and Typing

Illumina reads of the 72 MRSA ST5 isolates from humans with no swine contact and 82 LA-MRSA ST5 were uploaded into Galaxy along with two ST5 representative closed genomes: a HA-MRSA isolate from Japan (Mu3) and a representative poultry-adapted MRSA ST5 isolate (ED98) ([@B27]; [@B33]). For read-based SNP discovery, reads were aligned with Bowtie2 to the reference genome Mu50 ([@B31]). The resulting alignments were processed with Freebayes using the following threshold settings: mapping quality 30, base quality 20, coverage 30, and allelic frequency 0.9 ([@B13]). The two closed representative genomes, Mu3 and ED98, were analyzed using the contig-based workflow. Briefly, a panel of SNPs for each genome was obtained by aligning the genome against the reference strain, Mu50, using NUCmer. SNPs were called with delta-filter and show-snps distributed with the MUMmer package ([@B6]).

### SNP Curation

Several SNP curation strategies were used to correct for false positive calls ([@B9], [@B10]). First, reads were mapped against the reference genome Mu50 and false positives identified by Freebayes with the settings described. If reads were unavailable (Mu3 and ED98), the post-assembly workflow generated a reference-based NUCmer alignment and extracted SNPs as described above with filtering of false SNPs. SNPs located within excluded regions (repeat regions, bacteriophages, resistance cassettes, and IS elements) were removed. SNPs were further curated by extracting the 40 nucleotides surrounding each predicted SNP in the reference genome and completing a nucleotide BLAST against the query genomes ([@B1]). Finally, resulting alignments were parsed to remove SNP locations derived from ambiguous hits (≥2), low alignment quality or misalignments, non-uniformly distributed regions, and InDels, as previously described ([@B37]; [@B9], [@B10]). Also, multinucleotide insertions and deletions of polymorphic bases were not considered SNPs and were excluded.

### SNP Annotation

The curated cataloged SNPs from each query genome were merged into a single SNP panel that reported the allele, genic/intergenic status, SNP position, and annotation ([@B49]; [@B44]; [@B40]). This SNP discovery and validation pipeline allows for rapid typing of strains of unknown provenance by interrogating the captured allelic states from established SNP panels ([@B9]).

### SNP Distribution

From the distribution of SNPs along the Mu50 chromosome, potential mutational hotspots and genes under positive selection could be identified using custom scripts implemented on Galaxy ([@B14]; [@B37]; [@B15]).

### SNP Phylogeny

The identified curated SNP panel was used for phylogenetic reconstruction by maximum parsimony with PAUP v4.0a146 with 100 bootstrap replicates ([@B52]). The SNP tree was visualized in Geneious (vR9) and the majority consensus tree was built in Mesquite ([@B29]; [@B34]). Tree decorations were added using Evolview ([@B26]). Calculation of the consistency index for each SNP allowed for identification of parsimony informative SNPs and flag homoplastic SNPs, as described in our previous works ([@B10]; [@B40]). A Maximum Likelihood phylogenetic tree was additionally inferred using RAxML v8.2.11 with the GTR CAT model and 100 bootstrap replicates ([@B45]). The consensus tree was built and visualized in Geneious (vR9) ([@B29]).

Mobile Genetic Element Analysis
-------------------------------

Mobile genetic elements harboring AMR genes and virulence factors were detected as described previously and verified using Geneious 9.0.5 ([@B25], [@B24]; [@B17]). AMR genes detected with ResFinder were verified through draft genome analysis ([@B17]). The SCC*mec* type was determined using PCR and confirmed *in silico* ([@B24]). Immune evasion genes associated with the β-hemolysin converting bacteriophage were identified in these isolates using PCR and confirmed *in silico* ([@B25]).

Results
=======

Isolate Provenance and Sequence Information
-------------------------------------------

Swine associated LA-MRSA ST5 isolates were obtained from nasal swabs of healthy pigs or humans, none of which exhibited signs of MRSA infection, or from swabs of the environment within swine facilities. Clinical MRSA ST5 isolates were obtained from patients with MRSA related disease at two urban, university affiliated hospitals in California where the likelihood that patients had contact with swine was considered negligible. Draft genomes confirmed the MLST data indicating all isolates were ST5.

Draft genome sequences were generated for the 81 LA-MRSA ST5 isolates and 72 MRSA ST5 isolates from humans with no swine contact (**Supplementary Table [S1](#SM2){ref-type="supplementary-material"}**). Genome statistics are summarized in **Supplementary Table [S1](#SM2){ref-type="supplementary-material"}**.

Single Nucleotide Polymorphism Typing
-------------------------------------

For reference based SNP discovery, genomes were aligned to the closed genome of reference strain Mu50, a vancomycin resistant HA-MRSA isolate from Japan ([@B27]). The core genome was determined by excluding identified MGEs and repeats. Core genome SNP discovery identified 764 SNPs comprised of: 154 intergenic, 186 synonymous, and 424 non-synonymous SNPs (**Supplementary Tables [S2](#SM3){ref-type="supplementary-material"}**, **[S3](#SM4){ref-type="supplementary-material"}**). Further evaluation of non-synonymous SNPs indicated that eight were shared by swine associated LA-MRSA ST5 isolates and not present in isolates from humans with no swine contact, as listed in **Table [1](#T1){ref-type="table"}**. There were also two SNPs found only in MRSA ST5 isolates from humans with no swine contact (**Table [1](#T1){ref-type="table"}**) that were specific to clinical isolates. The genes harboring the non-synonymous SNPs distinct to each subset of isolates have not been implicated in virulence of *S. aureus* and are unlikely to contribute to the pathogenicity of these isolates. SNPs were distributed throughout the Mu50 reference genome and no mutational hotspots were observed (**Figure [1](#F1){ref-type="fig"}**).

###### 

Non-synonymous SNPs unique to LA-MRSA ST5 isolates or MRSA ST5 isolates from humans with no swine contact.

  Number of swine associated isolates   Number of isolates from humans with no swine contact   SNP position^a^   Gene product^b^
  ------------------------------------- ------------------------------------------------------ ----------------- ----------------------------------------------
  82/82                                 0/72                                                   160799            2′-3′-Cyclic-nucleotide 2′-phosphodiesterase
  82/82                                 0/72                                                   292343            Sorbitol dehydrogenase homolog
  82/82                                 0/72                                                   806489            Putative transporter
  82/82                                 0/72                                                   848820            Putative P-loop-containing kinase
  82/82                                 0/72                                                   1012841           Similar to ATP-dependent nuclease subunit A
  82/82                                 0/72                                                   1928498           *O*-Succinylbenzoic acid-CoA ligase
  82/82                                 0/72                                                   2695325           Ferrous iron transport protein B homolog
  82/82                                 0/72                                                   2720180           Regulatory protein
  0/82                                  69/72                                                  192929            Hypothetical protein
  0/82                                  69/72                                                  2277937           Conserved hypothetical protein

a

SNP position indicates the location of the SNP in the reference genome of Mu50.

b

Gene product represents the protein produced by the gene containing the SNP of interest.

![Genomic distribution of SNPs. The position of the 761 identified SNPs were plotted on the Mu50 chromosome using a sliding window of 1,000 bp. SNPs were distributed throughout regions included in the analysis and did not indicate any locations for mutational hotspots. Regions lacking SNP predictions are associated with locations of mobile genetic elements and repeat regions that were excluded from the SNP discovery and encode elements such as the SCC*mec* element and the β-hemolysin converting bacteriophage.](fmicb-09-02078-g001){#F1}

Phylogenetic Analysis
---------------------

A phylogenetic hypothesis was constructed from the identified core genome SNPs and rooted using the MRSA ST5 isolate Mu50. This tree depicts the evolutionary relationships between the 153 MRSA ST5 isolates and the reference isolates Mu3 and ED98 (**Figure [2](#F2){ref-type="fig"}**). The tree topology shows that swine associated LA-MRSA ST5 isolates cluster together and are separated from MRSA ST5 isolates from humans with no swine contact. These groups will be referred to as Clades I and II, representing MRSA ST5 isolates from humans with no swine contact and LA-MRSA ST5, respectively. A single MRSA ST5 isolate (UCSF14436) from a human with no swine contact was contained within Clade II. This isolate was the most distantly related of the Clade II isolates, harboring 24 unique/strain-specific SNPs. USCF14436 harbors a type IV SCC*mec* element and two AMR genes (*mecA* and *blaZ*), which is a strong indication this isolate is a CA-MRSA strain (**Figure [3](#F3){ref-type="fig"}**).

![Maximum parsimony SNP tree of ST5 MRSA isolates. Comparison of 156 genomes, including 153 MRSA ST5 isolates, Mu3, ED98, and Mu50, yielded a total of 764 SNPs, of which 247 were parsimony informative. The tree shown is a majority-consensus tree of 4,440 equally parsimonious trees with a consistency index of 0.9428. Trees were recovered using a heuristic search in Paup 4.0b10 ([@B52]). This tree is broken into clades, with Clade I representing clinical MRSA ST5 isolates from humans with no swine contact and Clade II representing LA-MRSA ST5 isolates. Clade IIa--d are subsets of LA-MRSA ST5 isolates and each subclade represents an individual farm or production system.](fmicb-09-02078-g002){#F2}

![Maximum parsimony SNP tree of ST5 MRSA isolates with MGE analysis. The SNP tree developed for **Figure [2](#F2){ref-type="fig"}** was decorated using Evolview ([@B26]). The tree shows the MGE complement of these isolates, specifically describing the SCC*mec* element, the β-hemolysin converting bacteriophage (harboring virulence factors involved in innate immune evasion), and antimicrobial resistance genes involved in tetracycline resistance (*tetT/tetL*) and macrolide resistance (*ermA* and *ermC*).](fmicb-09-02078-g003){#F3}

Methicillin resistant *S. aureus* ST5 isolates from humans with no swine contact (Clade I) are divided into subclades Ia and Ib. The SNP-level plasticity between MRSA ST5 isolates from humans with no swine contact is greater than that from LA-MRSA ST5 isolates. Despite the northern and southern geographic regions represented by the two groups of California isolates, the tree topology shows that UCSF isolates were found interspersed throughout Clade I and did not cluster by geographic location.

The swine associated isolates within Clade II formed four subclades, IIa--d. Each subclade represents a subset of isolates from a specific farm or farms; such that, Clade IIa represents isolates from Farm 10, Clade IIb represents isolates from Farm 24, Clade IIc represents isolates from Farm 46, and Clade IId represents isolates from Farms 38--42. Isolates originating from individual farms were genetically homogenous, possessing fewer than five SNPs (distinguishing them from other isolates from the same farm). These results suggest that LA-MRSA ST5 populations residing on farms are clonal and intermingling/transfer of isolates among farms or reintroduction of MRSA ST5 onto farms had likely not occurred. This was true for all swine associated isolates except those from Farms 38--42 (Clade IId). The high degree of genetic relatedness of the isolates within Clade IId suggests these farms are likely from a single production system or share a common genetic source, with exposure of pigs to LA-MRSA ST5 early in the production system (farrowing unit) and disseminated throughout the later stages as pigs are moved (finishing barns). High resolution profiling provides important phylogenetic signals for strain attribution ([@B10]; [@B40]). In this case, isolates from humans with short-term contact with swine farms could be traced back to a specific farm or production system. For example, isolates ISU886-ISU889 were traced to Farm 24, through SNP analysis. These isolates possessed the unique pattern of SNPs present on that farm or within that production system (Clade IIb, IIc, and IId), indicating exposure to the farm harboring that specific clone. The remaining isolates in Clade II include the isolates from humans with long-term swine contact and UCSF14436. Isolates from humans with long term swine contact did not cluster with isolates from the tested farms (**Figure [2](#F2){ref-type="fig"}**). This is consistent with the source of these isolates as it was unlikely the swine veterinarians sampled had contact with the specific farms sourcing the other swine associated isolates in this study. Though these isolates were distinct from the isolates obtained from swine, swine facilities, and humans with short term swine contact, they clustered together within Clade II and were representative of the livestock associated ST5 genotype. A Maximum-likelihood SNP tree was additionally constructed and revealed identical phylogenetic relationship between the MRSA ST5 isolates from humans with no swine contact and the swine-associated LA-MRSA ST5 isolates (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**).

Mobile Genetic Element Analysis
-------------------------------

The draft genomes of both LA-MRSA ST5 isolates and clinical MRSA ST5 isolates from humans with no swine contact were evaluated for MGEs. LA-MRSA ST5 isolates could also be distinguished from clinical MRSA ST5 isolates by the AMR genes and virulence factors they harbored (**Figure [3](#F3){ref-type="fig"}**). For LA-MRSA ST5 isolates, the SCC*mec* elements were of type III, IV, or untypable. Alternatively, clinical MRSA ST5 isolates harbored predominantly type II SCC*mec* elements and two type IV elements. Evaluation of the AMR genes revealed the primary macrolide resistance gene was *ermA* in clinical MRSA ST5 isolates, while LA-MRSA ST5 isolates harbored *ermC*. Additionally, tetracycline resistance genes were found exclusively in LA-MRSA ST5 isolates. Virulence factors harbored by the subsets were also different, with the majority (65/72, 90.3%) of clinical MRSA ST5 isolates harboring innate immune evasion genes within the β-hemolysin converting bacteriophage and none of the LA-MRSA ST5 isolates harboring these genes. This analysis revealed that MGE were not commonly shared between the two subsets of isolates.

Discussion
==========

Methicillin resistant *S. aureus* in livestock species was first identified in the 1970s ([@B8]); however, discovery of a high prevalence of MRSA ST398 in swine in 2005, and subsequently in other livestock, brought debate over its public health implications to the forefront ([@B50]). Previous studies investigating LA-MRSA ST398 demonstrated these isolates have adapted to livestock hosts. This was represented by the absence of human specific virulence factors, such as the β-hemolysin converting bacteriophage ([@B39]), and reduced adherence and transmission among humans ([@B16]; [@B49]). LA-MRSA ST9 isolates, similar to ST398, are thought to be livestock adapted, and clinical cases appear to be rare and attributed to animal contact ([@B5]). While the ST5 lineage in humans is globally distributed and successful in both the hospital and community settings ([@B36]), there are currently no reports of MRSA ST5 related disease occurring due to contact with livestock species; however, the genetic potential for swine isolates to adhere, invade, and cause disease in humans has not been investigated.

Here, we examined the phylogenetic relatedness applying high resolution core genome SNP profiling strategies on MRSA ST5 isolates from swine associated sources and humans with no swine contact to determine if distinct subpopulations of ST5 isolates exist within different host populations, which may provide evidence of host adaption. Similar analyses have been conducted for the ST398 lineage, where researchers identified that the studied LA-MRSA ST398 isolates were within the same clade and that clade appeared to have evolved from an ancestral human methicillin susceptible *S. aureus* (MSSA) ST398 clade ([@B39]).

In this study, isolates from humans with no swine contact clustered distinctly from swine associated LA-MRSA ST5 isolates. All swine associated LA-MRSA ST5 isolates were contained within Clade II, while all but one MRSA ST5 from humans with no swine contact belonged to Clade I. The MGE complement of this clinical MRSA ST5 isolate (UCSF14436) suggests that it is likely a CA-MRSA isolate. CA-MRSA isolates tend to be genetically distinct from HA-MRSA isolates ([@B46]), which may explain why UCSF14436 is found within the LA-MRSA clade. The separation of LA-MRSA ST5 isolates from clinical MRSA ST5 isolates based on their core genome relatedness supports our previous work, which indicated that swine associated LA-MRSA ST5 isolates harbor different MGEs containing virulence and resistance genes than MRSA ST5 from humans with no swine contact ([@B25], [@B24]; [@B17]). The data reported here further demonstrate the phylogenetic distinction of isolates into different groups and may reflect the adaptation of LA-MRSA ST5 isolates to colonization of swine. This distinction is based on focusing on MGEs harboring virulence factors and/or AMR and not on the full complement of all MGEs. This focus was warranted to begin evaluating the potential of LA-MRSA ST5 isolates to serve as a source for human infections or as a source for MGEs harboring virulence factors or AMR based on the isolates included in this study. Furthermore, similar to LA-MRSA ST398, evaluation of known virulence genes provides evidence that swine associated LA-MRSA ST5 may be less capable of causing disease in humans (**Figure [3](#F3){ref-type="fig"}**) ([@B25]). The *dN*/*dS* ratio observed within the core genome of the isolates was 2.3, which could potentially indicate that these strains recently evolved or underwent initial stages of diversification ([@B4]).

Our results indicate frequent introduction of MRSA ST5 onto swine farms is unlikely and dominant clones of MRSA ST5 circulated within each farm at the time of sampling. A high degree of genetic relatedness was identified among swine-associated isolates. As expected, the population of isolates found on individual farms were dominated by clonal populations. This indicates either a single introduction of LA-MRSA ST5 onto a farm or dominance of a single variant that precludes colonization with alternative isolates introduced by human caretakers. However, multiple *S. aureus* lineages and spa types often occur simultaneously on swine farms and in individual pigs ([@B32]), so the diversity of *S. aureus* in these animals may be underrepresented when looking specifically at MRSA ST5 isolates. This clonality was not present in isolates from humans with no swine contact, where genome plasticity was greater and individual isolates showed more diversity than that observed among LA-MRSA ST5 isolates.

While the evidence here suggests the populations of LA-MRSA ST5 and MRSA ST5 from humans with no swine contact are distinct, the isolates used in this analysis were sourced from geographically separated regions to ensure the clinical isolates were from patients with no swine contact. This design was utilized to build a solid reference point for comparing MRSA ST5 isolates from clinical and agricultural sources; however, because of the unlikelihood of these populations mingling, the SNPs identified can be attributed to either the geographic separation or the host species of the isolates. Future studies are warranted that include clinical MRSA ST5 isolates obtained from the hospital and community setting in areas of dense swine production, enabling further elucidation of the potential of LA-MRSA ST5 isolates to serve as a source for human infections or as a source for MGEs harboring virulence factors or AMR. As evidenced in this study, WGS followed by high resolution SNP profiling is a powerful molecular genomic epidemiology approach to gain insights into the population structure of LA-, CA-, and HA-MRSA and can provide important phylogenetic indicators for strain attribution.
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